Dr. Nathan J. Neufeld, DO

Dr. Neufeld practices at City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope.

Dr. Neufeld's NPI, 1497993067, was assigned on February 4, 2009. Dr. Neufeld graduated from Touro University Nevada in 2008. Dr. Neufeld holds Georgia license 071046.

Dr. Neufeld's primary practice is City of Hope Cancer Center Atlanta, at 600 Celebrate Life Parkway North, Newnan, GA 30265 in Coweta County. The practice phone is (404) 844-8334.

Dr. Neufeld's primary practice is City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope. The medical group on file is City of Hope Atlanta. Dr. Neufeld's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neufeld practices. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Neufeld's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Neufeld is board certified in 2022 - 2025 by the AL State License. Dr. Neufeld is licensed in Georgia.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain and thoracic spine disorders among the conditions Dr. Neufeld treats.

CMS data shows 396 Medicare services from Dr. Neufeld across 11 procedure codes in 2024, for 173 Medicare patients. Medicare paid $31,037 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Neufeld in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Neufeld's median patient age at 66, with 60% women.

In 2024, Dr. Neufeld wrote 932 Medicare Part D claims for 295 patients. 94% of them were for generic drugs. CMS names the drug for 872 of them, across 19 drugs with 11 or more claims each, at $34,133 in total drug cost. In 2023, CMS named 677 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Neufeld for performance year 2024, reported as part of a group. Dr. Neufeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Neufeld, published from 2012 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Quality Improvement. Dr. Neufeld has published most often in Am J Med Qual. Dr. Neufeld's most frequent co-authors are Ricardo Hugo Alvarez, MD, Philippines Garcia Cabahug, MD and Yian Chen, MD.

Dmand AI links Dr. Neufeld to 2 clinical trials.

CMS Open Payments shows 419 general payments to Dr. Neufeld from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Medtronic, Inc. paid the most, $126,864.

Dr. Neufeld graduated from Touro University Nevada in 2008. Dr. Neufeld is a member of AAPM, American College of Medical Quality, American Pain Society, American Society of Interventional Pain Physicians, American Society of Regional Anesthesia and Pain Medicine and Coweta Substance Abuse Prevention Coalition.

Dr. Neufeld is in network with 14 carriers, including United Healthcare, Elevance and HCSC. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.